Share on StockTwits

Otonomy (NASDAQ:OTIC) Insider A/S Novo bought 15,690 shares of the company’s stock on the open market in a transaction dated Tuesday, August 19th. The stock was purchased at an average cost of $15.50 per share, for a total transaction of $243,195.00. Following the transaction, the insider now directly owns 2,175,025 shares of the company’s stock, valued at approximately $33,712,888. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of Otonomy (NASDAQ:OTIC) traded up 1.94% on Thursday, hitting $16.30. The stock had a trading volume of 179,508 shares. Otonomy has a one year low of $15.19 and a one year high of $18.49. The stock’s 50-day moving average is $16.31 and its 200-day moving average is $16.31. The company’s market cap is $2.0 million.

Otonomy, Inc is a clinical-stage biopharmaceutical company. The Company focused on the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.